Staging of testis cancer: Combining serum markers, histologic parameters, and radiographic imaging

Urologic Clinics of North America

Volumn 25, Issue 3, 1998, Pages 397-403

  Gatti, J M ^a   Stephenson, R A ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; LACTATE DEHYDROGENASE; TUMOR MARKER;

CANCER INVASION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; HUMAN; ISOCHROMOSOME; LUNG METASTASIS; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE RAS; ORCHIECTOMY; PRIORITY JOURNAL; RETROPERITONEAL CANCER; REVIEW; SEMINOMA; TESTIS CANCER;

EID: 0031928865     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70030-6     Document Type: Article

References (44)

1. N.L. Bartlett F.S. Freiha F.M. Torti Serum markers in germ cell neoplasms Hematol Oncol Clin North Am 5 1991 1245 1261
2. J.R. Bloomer T.A. Waldmann K.R. McIntire Serum alpha-fetoprotein levels in patients with non-neoplastic liver disease Gastroenterology 65 1983 530
3. G. Bosl N. Geller C. Cirrincione Serum tumor markers in patients with metastatic germ cell tumors of the testis: A 10-year experience Am J Med 75 1983 29 35
4. J.A. Brewer E.S. Tank Yolk sac tumors and alpha-fetoprotein in the first year of life Urology 42 1993 79 80
5. B.T. Burney E.C. Klatte Ultrasound and computed tomography of the abdomen in staging and management of testicular carcinoma Radiology 132 1979 415 419
6. W.J. Catalona J.L. Vaitukaitis W.R. Fair Falsely positive specific human chorionic gonadotropin assays in patients with testicular tumors: Conversion to negative with testosterone administration J Urol 122 1979 126 128
7. W.T. de Riese P. Albers E.B. Walker Predictive parameters of biological behavior of early stage nonseminomatous testicular germ cell tumors Cancer 74 1994 1335 1341
8. J.P. Donohue J.M. Zachary B.R. Maynard Distribution of nodal metastases in nonseminomatous testis cancer J Urol 128 1982 315 320
9. J.H. Ellis J.R. Bies K.K. Kopecky Comparison of NMR and CT imaging in the evaluation of metastatic retroperitoneal lymphadenopathy from testicular carcinoma J Comput Assist Tomogr 8 1984 709 719
10. L.S. Freedman M.C. Parkinson W.G. Jones Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone Lancet 2 8554 1987 294 298
11. C.Y. Fung L.A. Kalish G.L. Brodsky Stage I nonseminomatous germ cell testicular tumor: Prediction of metastatic potential by primary histopathology J Clin Oncol 6 1988 1467 1473
12. S. Ganguly V.V.S. Murty F. Samaniego Detection of preferential N-ras mutations in human male germ cell tumors by the polymerase chain reaction Genes Chromosom Cancer 1 1990 228 232
13. J.P. Heiken H.P. Forman J.J. Brown Neoplasms of the bladder, prostate, and testis Radiol Clin North Am 32 1994 81 96
14. W.R. Hogeboom H.J. Hockstra E.L. Mooyaart MRI of retroperitoneal lymph node metastases of nonseminomatous germ cell tumors of the testis Eur J Surg Oncol 19 1993 429 437
15. J.E. Husband A. Barrett M.J. Peckham Evaluation of computed tomography in the management of testicular teratoma Br J Urol 53 1981 179 183
16. H. Kinumaki H. Takeuchi K. Makamura Serum lactate dehydrogenase isoenzyme-1 in children with yolk sac tumor Cancer 56 1985 178 181
17. E.A. Klein Tumor markers in testis cancer Urol Clin North Am 20 1993 67 73
18. O. Klepp A.M. Olsson H. Henrikson Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: Multivariate analysis of a prospective multicenter study J Clin Oncol 6 1990 509 518
19. K. Koshida A. Nishino H. Yamamoto The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors J Urol 146 1991 57 60
20. P. Lange L.E. Nochomontz J. Rosai Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma J Urol 124 1980 472 478
21. I. Leibovitch R.S. Foster K.K. Kopecky Improved accuracy of CT based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes J Urol 154 1995 1759 1763
22. J.W. Moul Proper staging techniques in testicular cancer Techniques in Urology 1 1995 126 132
23. J.W. Moul J.P. Foley C.L. Hitchcock Flow cytometric and quantitative histological parameters to predict occult disease in clinical stage I nonseminomatous germ cell tumors J Urol 150 1993 879 883
24. R.T. Oliver Testicular cancer Curr Opin Oncol 6 1994 285 291
25. G. Read S.P. Stenning M.H. Cullen Medical Research Council prospective study for surveillance for stage I testicular teratoma J Clin Oncol 10 1992 1762 1768
26. J.P. Richie Neoplasms of the testis P.C. Walsh A.B. Retik T.A. Stamey Campbell's Urology ed 6 1992 WB Saunders Philadelphia 1222 1263
27. J.P. Richie Testicular cancer: What staging investigations are indicated? Seminars in Urologic Oncology 14 1996 13 16
28. J.P. Richie M.B. Garnick H. Finberg Computerized tomography: How accurate for abdominal staging of testis tumors? J Urol 127 1982 715 717
29. J.P. Richie M.A. Socinsky L.Y. Fund Management of patients with clinical stage II nonseminomatous germ cell tumors of the testis Arch Surg 122 1987 1443 1445
30. P.N. Rodriguez G.R. Hafuz E.M. Messy Nonseminomatous germ cell tumor of the testicle: Does extensive staging of the primary tumor predict the likelihood of metastatic disease? J Urol 136 1986 604 608
31. R.G. Rowland R.S. Foster J.P. Dohohue Scrotum and testis J.Y. Gillenwater J.T. Grayhack S.S. Howards Adult and Pediatric Urology ed 3 1996 Mosby-Yearbook St. Louis 1917 1950
32. F. Samaniego E. Rodriguez J. Houldsworth Cytogenetic and molecular analysis of human male germ cell tumors: Chromosome 12 abnormalities and gene amplification Genes Chromosom Cancer 1 1990 289 292
33. L. Samuelson L. Frostberg A. Olson Accuracy of radiological staging procedures in nonseminomatous testis cancer compared with findings from surgical exploration and histopathological studies of extirpated tissue Br J Radiol 59 1986 131 134
34. W.A. See L. Hoxie Chest staging in testis cancer patients: Imaging modality selection based upon risk assessment as determined by abdominal CT scan results J Urol 150 1993 874 878
35. I.A. Sesterhenn R.B. Weiss F.K. Mostofi Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: A report from the Testicular Cancer Intergroup Study J Clin Oncol 10 1992 69 78
36. G.S. Steele J.P. Richie Current role of retroperitoneal lymph node dissection in testicular cancer Oncology 11 1997 717 729
37. A. Stephens J. Donohue G. Hutchins Positron emission tomography (PET) evaluation of residual radiographic abnormalities in post-chemotherapy germ cell tumors (GCT) Proceedings of ASCD 13 1994 239
38. T. Strohmeyer M. Geiser R. Ackermann Value of computed tomography in the staging of testicular tumors Urol Int 43 1988 198 200
39. T. Strohmeyer S. Peter M. Hartman Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors Cancer Res 51 1991 1811 1816
40. T. Strohmeyer P. Reissmann C. Cordon-Cordo Correlation between retinoblastoma gene expression and differentiation in human testicular tumors Proc Natl Acad Sci U S A 88 1991 6662 6666
41. A. Vos J.W. Oosterhuis B. de Jong Cytogenetics of carcinoma of the testis Cancer Genet Cytogenet 46 1990 75 81
42. D. Vugrin A. Friedman W.F. Whitmore Correlation of serum tumor markers in advanced germ cell tumors with response to chemotherapy and surgery Cancer 53 1984 1440 1445
43. H.N. Wagner A new approach to clinical decision-making in oncology Resident and Staff Physician 43 1997 12 22
44. K.I. Wishnow D.E. Johnson D.A. Swanson Identifying patients with low risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillance Urology 34 1989 339 343